Newly Diagnosed Multiple Myeloma Active Not Recruiting Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01936532Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)Treatment